3/13
09:15 am
lfwd
FDA Issues Clearance for ReWalk 7 Exoskeleton
Medium
Report
FDA Issues Clearance for ReWalk 7 Exoskeleton
3/11
02:22 pm
lfwd
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its price target lowered by analysts at Lake Street Capital from $4.50 to $4.00. They now have a "buy" rating on the stock.
Medium
Report
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its price target lowered by analysts at Lake Street Capital from $4.50 to $4.00. They now have a "buy" rating on the stock.
3/11
08:15 am
lfwd
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Medium
Report
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
3/7
08:00 am
lfwd
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
Low
Report
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
3/6
08:00 am
lfwd
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
Medium
Report
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
3/5
08:00 am
lfwd
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
Low
Report
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
2/28
08:00 am
lfwd
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
Medium
Report
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
2/20
01:28 pm
lfwd
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its price target lowered by analysts at Lake Street Capital from $6.00 to $4.50. They now have a "buy" rating on the stock.
Low
Report
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its price target lowered by analysts at Lake Street Capital from $6.00 to $4.50. They now have a "buy" rating on the stock.
2/20
08:00 am
lfwd
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
ReWalk Robotics Ltd. (NASDAQ: LFWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
2/19
09:10 am
lfwd
Lifeward Announces CEO Transition
High
Report
Lifeward Announces CEO Transition
2/10
07:19 am
lfwd
ReWalk Robotics Ltd. (NASDAQ: LFWD) is now covered by analysts at Laidlaw. They set a "buy" rating and a $10.00 price target on the stock.
High
Report
ReWalk Robotics Ltd. (NASDAQ: LFWD) is now covered by analysts at Laidlaw. They set a "buy" rating and a $10.00 price target on the stock.
2/5
08:00 am
lfwd
Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
Low
Report
Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
2/4
08:00 am
lfwd
Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
Low
Report
Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
1/30
05:12 am
lfwd
Gait Trainer Market Set to Grow from USD 395.6 Million in 2025 to USD 637.8 Million by 2035 at a 4.9% of CAGR, Driven by Advanced Technologies | Future Market Insights, Inc. [Yahoo! Finance]
Medium
Report
Gait Trainer Market Set to Grow from USD 395.6 Million in 2025 to USD 637.8 Million by 2035 at a 4.9% of CAGR, Driven by Advanced Technologies | Future Market Insights, Inc. [Yahoo! Finance]
1/13
08:30 am
lfwd
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
High
Report
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
1/13
07:45 am
lfwd
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
Medium
Report
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
1/8
04:15 pm
lfwd
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Medium
Report
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
1/7
08:05 am
lfwd
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
High
Report
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules